Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

If someone is experiencing homelessness, their smartphone often becomes their sole means of staying connected with loved ones and accessing critical services. Charging that phone can be challenging, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Knapsack raised $10 million from ...

Smart enough to be worn with a suit and full of smartly Considered features, but still with space for a middle-distance traveller, the Troubadour Apex 4.0 repays its high price with style and ...

Researchers from Samsung Electronic Co. Ltd. have created a tiny artificial intelligence model that punches far above its weight on certain kinds of “reasoning” tasks, challenging the industry’s ...